The proportion of CD127+ T-cells was decreased in BPH tissue compared to malignant PC lesions (median 52.5% vs. 69.2%, p = 0.007) and control prostates (median 52.5% vs. 71.4%, p = 0.001) (Figure 3D). The gene discussed is IL7R; the disease is benign prostatic hyperplasia.